Increased saturation of the fatty acids in the sn-2 position of phospholipids reduces cholesterol crystallization in model biles

被引:10
作者
Ringel, Y
Sömjen, GJ
Konikoff, FM
Rosenberg, R
Gilat, T
机构
[1] Ichilov Hosp, Dept Gastroenterol, Tel Aviv Souraski Med Ctr, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Minerva Ctr Cholesterol Gallstones & Lipid Metab, IL-64239 Tel Aviv, Israel
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1998年 / 1390卷 / 03期
关键词
model bile; phospholipid species; fatty acyl saturation; cholesterol crystallization;
D O I
10.1016/S0005-2760(97)00192-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Changes in the molecular structure of biliary phospholipids were shown to have major effects on cholesterol solubility, carriers and crystallization in human and model biles. This study investigated systematically the effects of varying saturation of the phosphatidylcholine (PC) sn-2 fatty acid on the cholesterol crystallization process in 3 different model biles. Twenty % of the egg PC (EPC) in these biles were replaced by synthetic PC's with 16:0-18:0, 16:0-18:1, or 16:0-18:2 fatty acyl chains. With 18:0 in the sn-2 position, the crystal observation time (GOT) was prolonged from 2 days in the control EPC solution to 14 days (P < 0.05). The crystal growth rate (CGR) was reduced from 0.1 OD/day to unmeasurable levels, and the total crystal mass on day 14 decreased by 86%. The introduction of one (18: 1), and two (18:2) double bonds in the sn-2 fatty acid rapidly reversed these effects. Ultracentrifugal analysis showed precipitable cholesterol as monohydrate crystals. In the 16:0-18:0 test solution, most of the precipitable cholesterol remained in the supersaturated multilamellar vesicles. Saturation of the biliary PC sn-2 fatty acyl chain prolongs the GOT, slows the CGR, reduces the crystal mass, and extends cholesterol solubility in multilamellar vesicles. Desaturation of the sn-2 fatty acid reverses these effects. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 19 条
[1]   DIFFERING EFFECTS OF NOR-URSODEOXYCHOLIC OR URSODEOXYCHOLIC ACID ON HEPATIC HISTOLOGY AND BILE-ACID METABOLISM IN THE RABBIT [J].
COHEN, BI ;
HOFMANN, AF ;
MOSBACH, EH ;
STENGER, RJ ;
ROTHSCHILD, MA ;
HAGEY, LR ;
YOON, YB .
GASTROENTEROLOGY, 1986, 91 (01) :189-197
[2]   DISSOLUTION OF CHOLESTEROL GALLSTONES BY CHENODEOXYCHOLIC ACID [J].
DANZINGER, RG ;
THISTLE, JL ;
SCHOENFIELD, LJ ;
HOFMANN, AF .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (01) :1-+
[3]   EFFECT OF PHOSPHOLIPIDS AND THEIR MOLECULAR-SPECIES ON CHOLESTEROL SOLUBILITY AND NUCLEATION IN HUMAN AND MODEL BILES [J].
HALPERN, Z ;
MOSHKOWITZ, M ;
LAUFER, H ;
PELED, Y ;
GILAT, T .
GUT, 1993, 34 (01) :110-115
[4]   PHARMACOLOGY OF URSODEOXYCHOLIC ACID, AN ENTEROHEPATIC DRUG [J].
HOFMANN, AF .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 :1-15
[5]   CHENOTHERAPY FOR GALLSTONE DISSOLUTION .2. INDUCED CHANGES IN BILE COMPOSITION AND GALLSTONE RESPONSE [J].
HOFMANN, AF ;
THISTLE, JL ;
KLEIN, PD ;
SZCZEPANIK, PA ;
YU, PYS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 239 (12) :1138-1144
[6]  
HOLAN KR, 1979, GASTROENTEROLOGY, V77, P611
[7]   LOW-DOSE URSODEOXYCHOLIC ACID PROLONGS CHOLESTEROL NUCLEATION TIME IN GALLBLADDER BILE OF PATIENTS WITH CHOLESTEROL GALLSTONES [J].
JUNGST, D ;
BRENNER, G ;
PRATSCHKE, E ;
PAUMGARTNER, G .
JOURNAL OF HEPATOLOGY, 1989, 8 (01) :1-6
[8]  
JUNGST D, 1993, J LIPID RES, V34, P1457
[9]  
KONIKOFF FM, 1994, J LIPID RES, V35, P60
[10]   Monitoring cholesterol crystallization from lithogenic model bile by time-lapse density gradient ultracentrifugation [J].
Konikoff, FM ;
Laufer, H ;
Messer, G ;
Gilat, T .
JOURNAL OF HEPATOLOGY, 1997, 26 (03) :703-710